Vaccine maker Bavarian Nordic confirms it’s in potential takeover talksnews2025-07-24T16:37:26+00:00July 24th, 2025|Endpoints News|
Rocket cuts 30% of staff as it plots path forward for gene therapiesnews2025-07-24T15:24:25+00:00July 24th, 2025|Endpoints News|
Novartis inks deal with covalent medicines biotech Matchpoint for $60M upfrontnews2025-07-24T14:34:47+00:00July 24th, 2025|Endpoints News|
AstraZeneca’s self-administered myasthenia gravis drug clears Phase 3 trialnews2025-07-24T11:38:53+00:00July 24th, 2025|Endpoints News|
Roche looks at direct-to-patient sales in the US, drops preclinical obesity drug from Carmot buynews2025-07-24T10:55:20+00:00July 24th, 2025|Endpoints News|
FDA delays review date for GSK’s multiple myeloma drug Blenrepnews2025-07-23T16:42:28+00:00July 23rd, 2025|Endpoints News|
Novo Nordisk loses Wegovy patent fight against generics maker Viatrisnews2025-07-23T15:59:22+00:00July 23rd, 2025|Endpoints News|
RFK Jr. adopts ACIP guidance to remove thimerosal from flu shotsnews2025-07-23T15:11:47+00:00July 23rd, 2025|Endpoints News|
CDMOs beat earnings expectations as clients navigate funding cuts and tariffsnews2025-07-23T15:00:25+00:00July 23rd, 2025|Endpoints News|
Makary’s new voucher program seeks ‘most favored nation’ pricingnews2025-07-22T19:07:03+00:00July 22nd, 2025|Endpoints News|
